Personal Care Products Council
Cosmetic industry trade association
Based in DC
AI Overview
With $1.7M in lobbying spend across 18 quarterly filings, Personal Care Products Council is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $510K |
| 2019 | $360K |
| 2020 | $370K |
| 2021 | $230K |
| 2022 | $270K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Consumer Issues
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products.
The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act.
The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Energy and Commerce Bipartisan Discussion Draft legislation to modernize regulatory framework for cosmetics and personal care products, Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279).
The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279).
The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act (H.R. 5141/S. 2886), Cosmetic Safety Enhancement Act of 2019 (H.R. 5279).
The FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.
Education and support for public policies to advance the modernization of FDA's regulation of cosmetics and OTC drugs.
Showing 8 of 11 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.